BRAINSTORM CELL THERAPEUTICS INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2023-07-19: Form 8-K; Exhibit 10.2; Description Placement Agency Agreement, dated as of July 17, 2023, by and between the Company and the placement agent party thereto..
- 2023-07-19: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement.
- 2023-01-04: Form 8-K; Exhibit 10.2; Description Separation Agreement, effective January 20, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Ralph Kern..
- 2023-01-04: Form 8-K; Exhibit 10.1; Description Amendment No. 3 to Offer Letter Agreement, dated January 3, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg..
| Filed | Form | Exhibit | Description |
|---|
| 2023-07-19 | 8-K | 10.2 | Placement Agency Agreement, dated as of July 17, 2023, by and between the Company and the placement agent party thereto. |
|---|
| 2023-07-19 | 8-K | 10.1 | Form of Securities Purchase Agreement |
|---|
| 2023-01-04 | 8-K | 10.2 | Separation Agreement, effective January 20, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Ralph Kern. |
|---|
| 2023-01-04 | 8-K | 10.1 | Amendment No. 3 to Offer Letter Agreement, dated January 3, 2023, between Brainstorm Cell Therapeutics Inc. and Dr. Stacy Lindborg. |
|---|